Citanest Forte Dental Injection, Solution
Product Images NDC 51004-5801

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Citanest Forte Dental (NDC 51004-5801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novocol Pharmaceutical Of Canada, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Citanestforte 01)

Chemical structure of prilocaine hydrochloride, showing the molecular arrangement with functional groups including an aromatic ring and a hydrochloride salt component.*

FDA Label Image

Chemical Structure (Citanestforte 02)

Chemical structure diagram depicting the molecular structure of the active ingredient, showing a benzene ring with hydroxyl groups and an attached side chain consistent with a local anesthetic compound.*

FDA Label Image

Principal Display Panel (50 Cartridge Carton)

Packaging label for Citanest Forte DENTAL 4% injection solution with epinephrine 1:200,000 by Dentsply Sirona. Contains prilocaine HCl 4% (40 mg/mL) with epinephrine 1:200,000. Manufactured by Novocol Pharmaceutical of Canada, Inc. Label shows 50 single-dose cartridges, 1.8 mL each, prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.